| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
1 | AN ACT concerning health benefits.
| |||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||||
4 | Section 5. The State Employees Group Insurance Act of 1971 | |||||||||||||||||||||
5 | is amended by changing Section 6 as follows:
| |||||||||||||||||||||
6 | (5 ILCS 375/6) (from Ch. 127, par. 526)
| |||||||||||||||||||||
7 | Sec. 6. Program of health benefits.
| |||||||||||||||||||||
8 | (a) The program of health benefits shall provide for | |||||||||||||||||||||
9 | protection
against the the financial costs of health care | |||||||||||||||||||||
10 | expenses incurred in and out
of hospital including basic | |||||||||||||||||||||
11 | hospital-surgical-medical coverages. The program
may include, | |||||||||||||||||||||
12 | but shall not be limited to, such supplemental coverages as
| |||||||||||||||||||||
13 | out-patient diagnostic X-ray and laboratory expenses, | |||||||||||||||||||||
14 | prescription drugs,
dental services, hearing evaluations, | |||||||||||||||||||||
15 | hearing aids, the dispensing and
fitting
of hearing aids, and | |||||||||||||||||||||
16 | similar group benefits
as are now or may become available. | |||||||||||||||||||||
17 | However, nothing in this Act shall
be construed to permit, on | |||||||||||||||||||||
18 | or after July 1, 1980, the non-contributory portion
of any such | |||||||||||||||||||||
19 | program to include the expenses of obtaining an abortion, | |||||||||||||||||||||
20 | induced
miscarriage or induced premature birth unless, in the | |||||||||||||||||||||
21 | opinion of a physician,
such procedures are necessary for the | |||||||||||||||||||||
22 | preservation of the life of the woman
seeking such treatment, | |||||||||||||||||||||
23 | or except an induced premature birth intended to
produce a live |
| |||||||
| |||||||
1 | viable child and such procedure is necessary for the health
of | ||||||
2 | the mother or the unborn child. The program may also include
| ||||||
3 | coverage for those who rely on treatment by prayer or spiritual | ||||||
4 | means
alone for healing in accordance with the tenets and | ||||||
5 | practice of a
recognized religious denomination.
| ||||||
6 | The program of health benefits shall be designed by the | ||||||
7 | Director
(1) to provide a reasonable relationship between the | ||||||
8 | benefits to be
included and the expected distribution of | ||||||
9 | expenses of each such type to
be incurred by the covered | ||||||
10 | members and dependents,
(2) to specify, as covered benefits and | ||||||
11 | as optional benefits, the
medical services of practitioners in | ||||||
12 | all categories licensed under the
Medical Practice Act of 1987, | ||||||
13 | (3) to include
reasonable controls, which may include | ||||||
14 | deductible and co-insurance
provisions, applicable to some or | ||||||
15 | all of the benefits, or a coordination
of benefits provision, | ||||||
16 | to prevent or minimize unnecessary utilization of
the various | ||||||
17 | hospital, surgical and medical expenses to be provided and
to | ||||||
18 | provide reasonable assurance of stability of the program, and | ||||||
19 | (4) to
provide benefits to the extent possible to members | ||||||
20 | throughout the
State, wherever located, on an equitable basis.
| ||||||
21 | Notwithstanding any other provision of this Section or Act,
for | ||||||
22 | all members or dependents who are eligible for benefits under | ||||||
23 | Social
Security or the
Railroad Retirement system or who had | ||||||
24 | sufficient Medicare-covered government
employment,
the
| ||||||
25 | Department shall reduce benefits
which would otherwise be paid | ||||||
26 | by Medicare, by the amount of benefits for
which the member or |
| |||||||
| |||||||
1 | dependents are eligible
under Medicare, except that such | ||||||
2 | reduction in benefits shall apply only to
those members or | ||||||
3 | dependents who (1) first become
eligible for such medicare | ||||||
4 | coverage on or after the effective date of this
amendatory Act | ||||||
5 | of 1992; or (2) are Medicare-eligible members or dependents of
| ||||||
6 | a local government unit which began participation in the | ||||||
7 | program on or after
July 1, 1992; or (3) remain eligible for | ||||||
8 | but no longer receive
Medicare coverage which they had been | ||||||
9 | receiving on or after the effective date
of this amendatory Act | ||||||
10 | of 1992.
| ||||||
11 | Notwithstanding any other provisions of this Act, where a | ||||||
12 | covered member or
dependents are eligible for benefits under | ||||||
13 | the federal Medicare health
insurance program (Title XVIII of | ||||||
14 | the Social Security Act as added by
Public Law 89-97, 89th | ||||||
15 | Congress), benefits paid under the State of Illinois
program or | ||||||
16 | plan will be reduced by the amount of benefits paid by | ||||||
17 | Medicare.
For members or dependents
who are eligible for | ||||||
18 | benefits under Social Security
or the Railroad Retirement | ||||||
19 | system or who had sufficient Medicare-covered
government | ||||||
20 | employment, benefits shall be reduced by the amount for which
| ||||||
21 | the member or dependent is eligible under Medicare,
except that | ||||||
22 | such reduction in benefits shall apply only to those
members or | ||||||
23 | dependents who (1) first become eligible for such
Medicare | ||||||
24 | coverage on or after the effective date of this amendatory Act
| ||||||
25 | of 1992; or (2) are Medicare-eligible members or dependents of | ||||||
26 | a local
government unit which began participation in the |
| |||||||
| |||||||
1 | program on or after July 1,
1992; or (3) remain eligible for, | ||||||
2 | but no longer receive Medicare
coverage which they had been | ||||||
3 | receiving on or after the effective date of this
amendatory Act | ||||||
4 | of 1992. Premiums may be adjusted, where applicable, to an
| ||||||
5 | amount deemed by the Director to be reasonably consistent with | ||||||
6 | any reduction
of benefits.
| ||||||
7 | (b) A member, not otherwise covered by this Act, who has | ||||||
8 | retired as a
participating member under Article 2 of the | ||||||
9 | Illinois Pension Code
but is ineligible for the retirement | ||||||
10 | annuity under Section 2-119 of the
Illinois
Pension Code, shall | ||||||
11 | pay the premiums for coverage, not
exceeding the amount paid by | ||||||
12 | the State for the non-contributory coverage for
other members, | ||||||
13 | under the group health benefits program under this Act. The
| ||||||
14 | Director shall determine the premiums to be paid
by a member | ||||||
15 | under this subsection (b).
| ||||||
16 | (Source: P.A. 93-47, eff. 7-1-03.)
| ||||||
17 | Section 10. The Illinois Public Aid Code is amended by | ||||||
18 | changing Section 5-5.12 as follows:
| ||||||
19 | (305 ILCS 5/5-5.12) (from Ch. 23, par. 5-5.12)
| ||||||
20 | Sec. 5-5.12. Pharmacy payments.
| ||||||
21 | (a) Every request submitted by a pharmacy for for | ||||||
22 | reimbursement under this
Article for prescription drugs | ||||||
23 | provided to a recipient of aid under this
Article shall include | ||||||
24 | the name of the prescriber or an acceptable
identification |
| |||||||
| |||||||
1 | number as established by the Department.
| ||||||
2 | (b) Pharmacies providing prescription drugs under
this | ||||||
3 | Article shall be reimbursed at a rate which shall include
a | ||||||
4 | professional dispensing fee as determined by the Illinois
| ||||||
5 | Department, plus the current acquisition cost of the | ||||||
6 | prescription
drug dispensed. The Illinois Department shall | ||||||
7 | update its
information on the acquisition costs of all | ||||||
8 | prescription drugs
no less frequently than every 30 days. | ||||||
9 | However, the Illinois
Department may set the rate of | ||||||
10 | reimbursement for the acquisition
cost, by rule, at a | ||||||
11 | percentage of the current average wholesale
acquisition cost.
| ||||||
12 | (c) (Blank).
| ||||||
13 | (d) The Department shall review utilization of narcotic | ||||||
14 | medications in the medical assistance program and impose | ||||||
15 | utilization controls that protect against abuse.
| ||||||
16 | (e) When making determinations as to which drugs shall be | ||||||
17 | on a prior approval list, the Department shall include as part | ||||||
18 | of the analysis for this determination, the degree to which a | ||||||
19 | drug may affect individuals in different ways based on factors | ||||||
20 | including the gender of the person taking the medication. | ||||||
21 | (f) The Department shall cooperate with the Department of | ||||||
22 | Public Health and the Department of Human Services Division of | ||||||
23 | Mental Health in identifying psychotropic medications that, | ||||||
24 | when given in a particular form, manner, duration, or frequency | ||||||
25 | (including "as needed") in a dosage, or in conjunction with | ||||||
26 | other psychotropic medications to a nursing home resident or to |
| |||||||
| |||||||
1 | a resident of a facility licensed under the ID/DD Community | ||||||
2 | Care Act or the MC/DD Act, may constitute a chemical restraint | ||||||
3 | or an "unnecessary drug" as defined by the Nursing Home Care | ||||||
4 | Act or Titles XVIII and XIX of the Social Security Act and the | ||||||
5 | implementing rules and regulations. The Department shall | ||||||
6 | require prior approval for any such medication prescribed for a | ||||||
7 | nursing home resident or to a resident of a facility licensed | ||||||
8 | under the ID/DD Community Care Act or the MC/DD Act, that | ||||||
9 | appears to be a chemical restraint or an unnecessary drug. The | ||||||
10 | Department shall consult with the Department of Human Services | ||||||
11 | Division of Mental Health in developing a protocol and criteria | ||||||
12 | for deciding whether to grant such prior approval. | ||||||
13 | (g) The Department may by rule provide for reimbursement of | ||||||
14 | the dispensing of a 90-day supply of a generic or brand name, | ||||||
15 | non-narcotic maintenance medication in circumstances where it | ||||||
16 | is cost effective. | ||||||
17 | (g-5) On and after July 1, 2012, the Department may require | ||||||
18 | the dispensing of drugs to nursing home residents be in a 7-day | ||||||
19 | supply or other amount less than a 31-day supply. The | ||||||
20 | Department shall pay only one dispensing fee per 31-day supply. | ||||||
21 | (h) Effective July 1, 2011, the Department shall | ||||||
22 | discontinue coverage of select over-the-counter drugs, | ||||||
23 | including analgesics and cough and cold and allergy | ||||||
24 | medications. | ||||||
25 | (h-5) On and after July 1, 2012, the Department shall | ||||||
26 | impose utilization controls, including, but not limited to, |
| |||||||
| |||||||
1 | prior approval on specialty drugs, oncolytic drugs, drugs for | ||||||
2 | the treatment of HIV or AIDS, immunosuppressant drugs, and | ||||||
3 | biological products in order to maximize savings on these | ||||||
4 | drugs. The Department may adjust payment methodologies for | ||||||
5 | non-pharmacy billed drugs in order to incentivize the selection | ||||||
6 | of lower-cost drugs. For drugs for the treatment of AIDS, the | ||||||
7 | Department shall take into consideration the potential for | ||||||
8 | non-adherence by certain populations, and shall develop | ||||||
9 | protocols with organizations or providers primarily serving | ||||||
10 | those with HIV/AIDS, as long as such measures intend to | ||||||
11 | maintain cost neutrality with other utilization management | ||||||
12 | controls such as prior approval.
For hemophilia, the Department | ||||||
13 | shall develop a program of utilization review and control which | ||||||
14 | may include, in the discretion of the Department, prior | ||||||
15 | approvals. The Department may impose special standards on | ||||||
16 | providers that dispense blood factors which shall include, in | ||||||
17 | the discretion of the Department, staff training and education; | ||||||
18 | patient outreach and education; case management; in-home | ||||||
19 | patient assessments; assay management; maintenance of stock; | ||||||
20 | emergency dispensing timeframes; data collection and | ||||||
21 | reporting; dispensing of supplies related to blood factor | ||||||
22 | infusions; cold chain management and packaging practices; care | ||||||
23 | coordination; product recalls; and emergency clinical | ||||||
24 | consultation. The Department may require patients to receive a | ||||||
25 | comprehensive examination annually at an appropriate provider | ||||||
26 | in order to be eligible to continue to receive blood factor. |
| |||||||
| |||||||
1 | (i) On and after July 1, 2012, the Department shall reduce | ||||||
2 | any rate of reimbursement for services or other payments or | ||||||
3 | alter any methodologies authorized by this Code to reduce any | ||||||
4 | rate of reimbursement for services or other payments in | ||||||
5 | accordance with Section 5-5e. | ||||||
6 | (j) On and after July 1, 2012, the Department shall impose | ||||||
7 | limitations on prescription drugs such that the Department | ||||||
8 | shall not provide reimbursement for more than 4 prescriptions, | ||||||
9 | including 3 brand name prescriptions, for distinct drugs in a | ||||||
10 | 30-day period, unless prior approval is received for all | ||||||
11 | prescriptions in excess of the 4-prescription limit. Drugs in | ||||||
12 | the following therapeutic classes shall not be subject to prior | ||||||
13 | approval as a result of the 4-prescription limit: | ||||||
14 | immunosuppressant drugs, oncolytic drugs, anti-retroviral | ||||||
15 | drugs, and, on or after July 1, 2014, antipsychotic drugs. On | ||||||
16 | or after July 1, 2014, the Department may exempt children with | ||||||
17 | complex medical needs enrolled in a care coordination entity | ||||||
18 | contracted with the Department to solely coordinate care for | ||||||
19 | such children, if the Department determines that the entity has | ||||||
20 | a comprehensive drug reconciliation program. | ||||||
21 | (k) No medication therapy management program implemented | ||||||
22 | by the Department shall be contrary to the provisions of the | ||||||
23 | Pharmacy Practice Act. | ||||||
24 | (l) Any provider enrolled with the Department that bills | ||||||
25 | the Department for outpatient drugs and is eligible to enroll | ||||||
26 | in the federal Drug Pricing Program under Section 340B of the |
| |||||||
| |||||||
1 | federal Public Health Services Act shall enroll in that | ||||||
2 | program. No entity participating in the federal Drug Pricing | ||||||
3 | Program under Section 340B of the federal Public Health | ||||||
4 | Services Act may exclude Medicaid from their participation in | ||||||
5 | that program, although the Department may exclude entities | ||||||
6 | defined in Section 1905(l)(2)(B) of the Social Security Act | ||||||
7 | from this requirement. | ||||||
8 | (Source: P.A. 98-463, eff. 8-16-13; 98-651, eff. 6-16-14; | ||||||
9 | 99-180, eff. 7-29-15.)
|